Ehlers-Danlos Syndrome Treatment in Houston: Relief from EDS-Related Pain and Symptoms

Ehlers-Danlos Syndrome is a group of heritable connective tissue disorders caused by defects in collagen production or structure. Collagen is the primary structural protein in connective tissues throughout your body, providing support to your skin, joints, blood vessels, and organs. When collagen doesn’t function properly, it creates a constellation of symptoms that can affect virtually every body system.

The 2017 classification identifies 13 types of EDS, each with unique genetic causes and symptoms. The most common types include hypermobile EDS (hEDS), which accounts for 80 to 90% of all EDS cases and is characterized by widespread joint hypermobility and chronic pain; classical EDS (cEDS), characterized by skin hyperextensibility, joint hypermobility, and tissue fragility; and vascular EDS (vEDS), which affects blood vessels and organs and can be life-threatening.

The hallmark features of most types of EDS include joint hypermobility (an unusually large range of joint movement), skin hyperextensibility (stretchy, velvety skin in some types), and tissue fragility (easy bruising, poor wound healing, and in some types, fragile blood vessels and organs).

However, EDS is far more than just being “double-jointed.” The condition causes joint instability and dislocations, chronic widespread pain, easy bruising and bleeding, digestive problems (gastroparesis, GERD, IBS), autonomic dysfunction (POTS, dysautonomia), chronic fatigue, headaches and migraines, cognitive difficulties, and significant functional impairment.

The experience of living with EDS is profoundly challenging. You look healthy to others, so they don’t understand why you’re in pain or why you can’t do certain activities. Joints that dislocate easily make it hard to trust your own body. The unpredictability of symptoms makes planning difficult. Many people with EDS have spent years seeking diagnosis, often being dismissed or misdiagnosed with conditions like fibromyalgia, chronic fatigue syndrome, or even told their symptoms are psychological.

Chronic pain in EDS is highly prevalent, associated with regular use of analgesics, and more prevalent and severe in the hypermobility type than in the classic type PubMed. The pain mechanisms in EDS are complex and multifaceted, evolving over time as the condition progresses.

Initially, pain in EDS is primarily nociceptive, caused by actual tissue damage from joint instability, subluxations, dislocations, and micro-trauma. Your loose joints and fragile tissues are constantly being injured, even by normal daily activities. Over time, repeated injuries and chronic inflammation lead to neuropathic pain from nerve damage. The unstable joints can compress or stretch nerves, causing burning, shooting, or electric-shock-like pain.

As EDS progresses, many people develop central sensitization. This is when your central nervous system becomes hypersensitized, amplifying pain signals and sometimes generating pain even when there’s no ongoing tissue damage. Your brain essentially “turns up the volume” on pain. This helps explain why pain in EDS often seems out of proportion to visible injury and why it can spread to areas that weren’t originally affected.

Research shows that pain severity in EDS correlates with the degree of hypermobility, number of dislocations, and previous surgeries. The pain contributes significantly to functional impairment in daily life, independent of fatigue levels. Many people with EDS also experience poor sleep quality due to pain, which creates a vicious cycle of increased pain sensitivity.

When someone with EDS tries standard pain treatments without achieving adequate relief, they experience what’s essentially treatment-resistant chronic pain. Traditional treatment for EDS-related pain typically involves physical therapy (strengthening and joint stabilization), bracing and orthotics, pain medications (NSAIDs, nerve pain medications, sometimes opioids), interventional procedures (injections, nerve blocks), lifestyle modifications, and management of co-occurring conditions.

While these approaches help many people, a significant percentage continues experiencing severe, disabling pain. Pharmacological management is limited by lack of evidence, and current treatments are supported by extrapolation of data from studies in non-EDS patients PubMed Central. Nerve pain medications like gabapentin can cause sedation and cognitive side effects. Opioids provide incomplete relief and come with risks of tolerance and dependence. Physical therapy can be helpful but must be carefully tailored to avoid causing more joint damage.

The reasons for treatment resistance in EDS are complex. The underlying connective tissue disorder continues causing new injuries. Central sensitization doesn’t respond well to peripheral treatments. Many people with EDS have comorbid conditions like mast cell activation syndrome, POTS, or gastroparesis that complicate pain management. Some individuals metabolize medications differently due to genetic factors.

The frustration of living with treatment-resistant EDS pain can be devastating. Due to lack of a cure and what can be seen by the patient as failed treatments, patients can lose faith in the healthcare system, which may discourage EDS patients from accessing needed healthcare as the disease progresses NCBI. We want you to know that innovative treatments are available that work through entirely different mechanisms than what you’ve tried before.

Your journey toward better symptom management begins with a thorough assessment at no cost. We need to understand your unique experience with EDS to develop the most effective treatment plan.

During your consultation, we’ll discuss:

• Your EDS type and diagnosis history
• Pain patterns and severity (location, quality, triggers)
• Joint hypermobility and dislocation frequency
• Co-occurring conditions (POTS, MCAS, gastroparesis)
• Previous treatments and what worked or didn’t
• Current medications and their effectiveness
• How EDS impacts your daily functioning
• Autonomic symptoms and fatigue levels
• Your treatment goals and priorities
• Which innovative treatments might work for your situation

There’s no obligation to continue, and everything we discuss remains completely confidential. We understand that EDS is a complex, multisystem condition, and we approach these conversations with expertise and empathy.

If you decide to proceed, we’ll develop a comprehensive treatment plan designed specifically for your EDS symptoms.

Your personalized plan considers:

• EDS type and severity
• Primary symptoms (pain, autonomic dysfunction, fatigue)
• Pain mechanisms (nociceptive, neuropathic, central sensitization)
• Co-occurring conditions that affect treatment
• Previous treatment responses
• Medication sensitivities
• Your functional goals and priorities
• Whether you need extended infusion protocols for complex pain
• How to integrate our treatments with existing EDS management

IMPORTANT: For Ehlers-Danlos Syndrome, ketamine infusions may last longer (up to 4 hours) compared to standard mental health treatments (40 minutes). This extended duration allows us to address the multiple pain mechanisms and complex symptoms characteristic of EDS. You’ll also need approximately 2 hours of recovery time after longer infusions before leaving our facility.

Some patients benefit most from a series of ketamine infusions for breakthrough pain relief and central sensitization. Others use our treatments as part of ongoing EDS management alongside physical therapy, medications, and other interventions. We tailor the approach to your specific needs and symptom severity.

Every treatment session at Catalyst takes place in a comfortable environment with continuous medical monitoring.

What makes treatment at Catalyst different for EDS patients:

• Extended hours: 5am to 9pm, seven days a week
• Flexible scheduling accommodating flare-ups
• Understanding of joint hypermobility (careful IV placement)
• Comfortable recliners with proper support
• Led by Dr. Ho, anesthesiologist with pain expertise
• Continuous monitoring throughout treatment
• Understanding of EDS as a complex, multisystem condition
• Compassionate, validating care

Dr. Ho’s expertise as an anesthesiologist means he has extensive experience managing complex pain conditions and placing IVs carefully in people with fragile tissues or difficult veins. We understand that people with EDS may have increased sensitivity to medications and may need careful monitoring. Whether you’re receiving ketamine, TMS, Spravato, or stellate ganglion block, our medical team monitors you carefully and adjusts treatment as needed.

We understand that EDS causes good days and bad days, and that joint dislocations or flares can happen unpredictably. If you need to reschedule due to symptoms, we work with you to find a better time.

Typical treatment protocols for Ehlers-Danlos Syndrome:

• Ketamine: 6-10 infusions (potentially longer duration) over 2-4 weeks initially
• TMS: Daily sessions over 4-6 weeks
• Spravato: Twice weekly initially for co-occurring depression
• Stellate Ganglion Block: 1-3 treatments for autonomic symptoms
• Maintenance: Regular booster treatments to sustain symptom relief

After your initial treatment series, we develop a maintenance plan. Many EDS patients need periodic booster treatments to maintain improved pain control and functioning. Some schedule monthly ketamine infusions to keep central sensitization under control. Others use treatments as needed during severe flares.

We’re committed to your long-term EDS management. Regular follow-up appointments help us monitor your symptoms, adjust treatment as needed, coordinate with your EDS specialists and physical therapists, and ensure you have the best possible quality of life given the constraints of your condition.

We understand that Ehlers-Danlos Syndrome is a complex, multisystem connective tissue disorder. You won’t hear dismissive comments about your symptoms being exaggerated from our team. We approach EDS with the expertise and validation this condition deserves.

We offer treatment protocols specifically designed for complex chronic pain conditions like EDS. This includes longer ketamine infusions to address multiple pain mechanisms simultaneously and understanding of how EDS affects various body systems.

Dr. Ho’s background as an anesthesiologist means he has extensive training in managing complex pain conditions like Ehlers-Danlos Syndrome. His expertise is particularly valuable for patients who need comprehensive, multi-mechanism pain management.

We understand that people with EDS may have tissue fragility, difficult veins, increased medication sensitivity, and higher risk of bruising. Our medical team takes extra care with procedures like IV placement and monitors you closely throughout treatment.

We work closely with your EDS specialists, physical therapists, and other providers to ensure coordinated care. Our treatments complement traditional EDS management approaches rather than replacing them. We can provide breakthrough pain relief while you continue building strength and stability through physical therapy.

Many people with EDS also struggle with chronic pain, fibromyalgia, migraines, depression, anxiety, or PTSD. We can address these co-occurring conditions as part of your comprehensive treatment plan.